1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow ecallantide: new trials by email Literature Review of ecallantide trials Research Report on ecallantide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess the Safety and Tolerability of a Single Administration of FOV2302 (Ecallantide) in Patients With Macular Edema Associated With Central Retinal Vein Occlusion FOV2302 (Ecallantide) - Macular Edema, Central Retinal Vein Occlusion | Phase 1 | Terminated | Fovea Pharmaceuticals SA | 11 | 2009-09-01 | 2012-01-10 |
Macular Edema (1) · Retinal Vein Occlusion (1)
France (1)